Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Bionano Genomics Inc (BNGO)
Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 101,449
  • Shares Outstanding, K 35,348
  • Annual Sales, $ 27,800 K
  • Annual Income, $ -132,600 K
  • 60-Month Beta 2.21
  • Price/Sales 3.73
  • Price/Cash Flow N/A
  • Price/Book 0.43
Trade BNGO with:

Options Overview Details

View History
  • Implied Volatility 75.55% ( -17.20%)
  • Historical Volatility 67.21%
  • IV Percentile 5%
  • IV Rank 14.03%
  • IV High 191.95% on 06/22/23
  • IV Low 56.55% on 09/15/23
  • Put/Call Vol Ratio 0.07
  • Today's Volume 369
  • Volume Avg (30-Day) 186
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 74,706
  • Open Int (30-Day) 75,643

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.77
  • Number of Estimates 1
  • High Estimate -0.77
  • Low Estimate -0.77
  • Prior Year -1.10
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.66 +0.75%
on 10/04/23
3.86 -30.57%
on 09/05/23
-1.17 (-30.39%)
since 09/01/23
3-Month
2.66 +0.75%
on 10/04/23
6.76 -60.33%
on 07/13/23
-3.68 (-57.84%)
since 07/03/23
52-Week
2.66 +0.75%
on 10/04/23
30.10 -91.10%
on 11/15/22
-17.72 (-86.86%)
since 10/04/22

Most Recent Stories

More News
Bionano Genomics (BNGO) Challengers: 3 Biotech Innovators to Buy Instead

With the rising aging population and the emergence of new diseases, the biotech industry appears poised for steady growth. Therefore, three quality biotech stocks, Vanda Pharmaceuticals (VNDA), Organogenesis...

BNGO : 2.68 (-6.62%)
EXEL : 21.76 (-0.55%)
ORGO : 2.86 (-2.72%)
VNDA : 4.30 (+4.12%)
Bionano Genomics (BNGO) vs. Gilead Sciences (GILD): Buy, Hold or Sell these Biotech Stocks?

As the biotech industry reaches new heights with innovation and the accessibility of big data, let us analyze whether biotech stocks Bionano Genomics and Gilead Sciences are a Buy, Hold, or Sell... ...

BNGO : 2.68 (-6.62%)
GILD : 74.74 (+2.01%)
MRK : 102.17 (+0.39%)
Why Bionano Genomics Stock Tanked Today

A CFO departure shines a light on some of the company's recent struggles.

AIG : 59.36 (+1.23%)
DGX : 122.58 (+1.28%)
BNGO : 2.68 (-6.62%)
Which Stock Do Investors Consider a Heathier Investment: Bionano Genomics (BNGO) vs. Corcept Therapeutics (CORT)

The biotech industry is poised for long-term growth supported by government initiatives and the rising prevalence of chronic illnesses. While biotech stocks Bionano Genomics (BNGO) and Corcept Therapeutics...

BNGO : 2.68 (-6.62%)
CORT : 25.90 (-1.03%)
Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript

BNGO earnings call for the period ending June 30, 2023.

BNGO : 2.68 (-6.62%)
2 Biotech Stocks You Should Buy While You Can, 1 That Investors Are Avoiding

The biotech industry is well-positioned for solid growth, thanks to the rising need for high-quality healthcare and the government's push to increase domestic biotech production and research. To that end,...

BNGO : 2.68 (-6.62%)
GILD : 74.74 (+2.01%)
JAZZ : 126.95 (+0.03%)
Are These Biotech Stocks a Buy or Sell for August: Bionano Genomics (BNGO) vs. Cidara Therapeutics (CDTX)?

Underpinned by undeniable growth trends of an aging population, breakthrough therapies, and the inelastic demand for healthcare products and medicines, the biotech industry is expected to perform well...

BNGO : 2.68 (-6.62%)
CDTX : 0.9300 (+0.56%)
Should You Watch Bionano Genomics (BNGO) this Week?

While Bionano Genomics (BNGO) is witnessing steady revenue growth, its bottom line remains in the red. Let’s dive deeper into its key financial metrics to analyze if BNGO is worth adding to your watchlists......

ALKS : 28.03 (+0.68%)
BIIB : 257.16 (+2.33%)
BNGO : 2.68 (-6.62%)
GILD : 74.74 (+2.01%)
Is Bionano Genomics (BNGO) a Buy or Sell this Week?

Genomic testing devices manufacturer Bionano Genomics (BNGO) is witnessing steady revenue growth. However, unfortunately, it did not translate into a bottom-line improvement. Moreover, as BNGO faces the...

ALKS : 28.03 (+0.68%)
BIIB : 257.16 (+2.33%)
BNGO : 2.68 (-6.62%)
SMLR : 26.85 (+2.40%)
Is Now the Time to Buy Bionano Genomics (BNGO)?

Biotech company Bionano Genomics (BNGO) has significant topline growth under its belt. However, its bottom line outlook is concerning. Would it be wise to invest in the stock now? Let’s look at some...

ALKS : 28.03 (+0.68%)
BIIB : 257.16 (+2.33%)
BNGO : 2.68 (-6.62%)
GILD : 74.74 (+2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 3.01
2nd Resistance Point 2.93
1st Resistance Point 2.81
Last Price 2.68
1st Support Level 2.61
2nd Support Level 2.53
3rd Support Level 2.41

See More

52-Week High 30.10
Fibonacci 61.8% 19.62
Fibonacci 50% 16.38
Fibonacci 38.2% 13.14
Last Price 2.68
52-Week Low 2.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar